Pricing Log in Create free account

Alector, Inc. (ALEC) vs Scribe Therapeutics Inc. (SCTX)

Alector, Inc. and Scribe Therapeutics Inc. are both Biotechnology companies. Alector, Inc. and Scribe Therapeutics Inc. are of similar size ($309.9M and $293.1M). Across the 3 metrics below, Scribe Therapeutics Inc. leads on 2 and Alector, Inc. on 1.

Valuation

Metric ALEC SCTX Biotechnology median
P/E 6.57 — 10.60
P/S 1.49 n/m 9.40
P/B 2.22 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.80 n/m 9.02
Earnings yield 15.22% — (32.88%)
Free cash flow yield (58.00%) 0.00% (23.13%)

Profitability

Metric ALEC SCTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 20.16% — 0.00%
Net margin 23.87% — 0.00%
Free cash flow margin (86.40%) — 0.00%
Return on equity 47.52% — (51.96%)
Return on assets 16.53% — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC SCTX Biotechnology median
Revenue growth (TTM) 151.23% — 6.76%
EPS growth (last fiscal year) (13.01%) — 29.88%
Revenue growth, 5-year CAGR (0.05%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALEC SCTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.10 0.57 4.97
Net debt to EBITDA 1.61 0.00 1.01

Dividend

Metric ALEC SCTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALEC SCTX Biotechnology median
Market cap 309.86m 293.06m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack